World's Best Scientists 2026 revealed!

D-Index & Metrics

Molecular Biology

D-Index
52
Citations
9904
World Ranking
2438
National Ranking
1200

Carolyn A. Felix publication distribution in Molecular Biology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Molecular Biology in 2026. The highlighted bar marks where Carolyn A. Felix sits on this spectrum.

47–56 publications: 7 scientists 57–66 publications: 17 scientists 67–76 publications: 65 scientists 77–86 publications: 90 scientists 87–96 publications: 125 scientists 97–106 publications: 131 scientists 107–116 publications: 162 scientists 117–126 publications: 177 scientists 127–136 publications: 158 scientists 137–146 publications: 158 scientists 147–156 publications: 146 scientists 157–166 publications: 159 scientists 167–176 publications: 131 scientists 177–186 publications: 110 scientists 187–196 publications: 112 scientists 197–206 publications: 100 scientists 207–216 publications: 89 scientists 217–226 publications: 98 scientists 227–236 publications: 74 scientists 237–246 publications: 72 scientists 247–256 publications: 63 scientists 257–266 publications: 53 scientists 267–276 publications: 54 scientists 277–286 publications: 49 scientists 287–296 publications: 52 scientists 297–306 publications: 43 scientists 307–316 publications: 46 scientists 317–326 publications: 41 scientists 327–336 publications: 42 scientists 337–346 publications: 31 scientists 347–356 publications: 28 scientists 357–366 publications: 29 scientists 367–376 publications: 26 scientists 377–386 publications: 24 scientists 387–396 publications: 24 scientists 397–406 publications: 14 scientists 407–416 publications: 13 scientists 417–426 publications: 20 scientists 427–436 publications: 12 scientists 437–446 publications: 20 scientists 447–456 publications: 11 scientists 457–466 publications: 10 scientists 467–476 publications: 14 scientists 477–486 publications: 14 scientists 487–496 publications: 10 scientists 497–506 publications: 13 scientists 507–516 publications: 13 scientists 517–526 publications: 2 scientists 527–536 publications: 4 scientists 537–546 publications: 6 scientists 547–556 publications: 8 scientists 557–563 publications: 6 scientists 564+ publications: 100 scientists
47 publications 564+

This scientist: 132 publications — 29th percentile

29% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 564 publications or more.

Carolyn A. Felix D-index placement in Molecular Biology in 2026

The chart shows the D-index (discipline H-index) distribution of Molecular Biology scientists ranked by Research.com in 2026. The highlighted bar marks where Carolyn A. Felix sits on this spectrum.

40–41 D-Index: 36 scientists 42–43 D-Index: 101 scientists 44–45 D-Index: 115 scientists 46–47 D-Index: 121 scientists 48–49 D-Index: 118 scientists 50–51 D-Index: 130 scientists 52–53 D-Index: 106 scientists 54–55 D-Index: 116 scientists 56–57 D-Index: 113 scientists 58–59 D-Index: 129 scientists 60–61 D-Index: 120 scientists 62–63 D-Index: 105 scientists 64–65 D-Index: 131 scientists 66–67 D-Index: 95 scientists 68–69 D-Index: 97 scientists 70–71 D-Index: 106 scientists 72–73 D-Index: 83 scientists 74–75 D-Index: 89 scientists 76–77 D-Index: 77 scientists 78–79 D-Index: 70 scientists 80–81 D-Index: 73 scientists 82–83 D-Index: 60 scientists 84–85 D-Index: 48 scientists 86–87 D-Index: 45 scientists 88–89 D-Index: 50 scientists 90–91 D-Index: 31 scientists 92–93 D-Index: 51 scientists 94–95 D-Index: 43 scientists 96–97 D-Index: 38 scientists 98–99 D-Index: 39 scientists 100–101 D-Index: 41 scientists 102–103 D-Index: 29 scientists 104–105 D-Index: 33 scientists 106–107 D-Index: 35 scientists 108–109 D-Index: 20 scientists 110–111 D-Index: 38 scientists 112–113 D-Index: 19 scientists 114–115 D-Index: 28 scientists 116–117 D-Index: 13 scientists 118–119 D-Index: 23 scientists 120–121 D-Index: 16 scientists 122–123 D-Index: 15 scientists 124–125 D-Index: 11 scientists 126–127 D-Index: 21 scientists 128–129 D-Index: 7 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 14 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 9 scientists 138–139 D-Index: 8 scientists 140–141 D-Index: 16 scientists 142–143 D-Index: 7 scientists 144 D-Index: 7 scientists 145+ D-Index: 100 scientists
40 D-Index 145+

This scientist: 52 D-Index — 22nd percentile

22% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 145 D-Index or more.

Overview

Carolyn A. Felix is affiliated with the Children's Hospital of Philadelphia in the United States. Their research primarily focuses on the fields of biochemistry, genetics, and molecular biology as well as medicine. Within these broad areas, their work spans key subfields including molecular biology, public health, environmental and occupational health, immunology, hematology, and genetics.

The scientist's research topics cover a range of areas related to cellular and molecular mechanisms, particularly in disease contexts. Main topics include:

  • Acute lymphoblastic leukemia research
  • RNA modifications and cancer
  • Biochemical and molecular research
  • Epigenetics and DNA methylation
  • Immune cell function and interaction
  • Hematopoietic stem cell transplantation
  • Genetics and neurodevelopmental disorders

Carolyn A. Felix has contributed to several recent publications that provide insight into disease mechanisms and genetic factors. Notable papers include:

  • "Single-cell multiomics reveals increased plasticity, resistant populations, and stem-cell-like blasts in KMT2A-rearranged leukemia," 2021, Blood
  • "Expanding the genotypic and phenotypic spectrum in a diverse cohort of 104 individuals with Wiedemann-Steiner syndrome," 2021, American Journal of Medical Genetics Part A
  • "Leukemia-associated transcription factor mllt3 is important for primitive erythroid development in zebrafish embryogenesis," 2022, Developmental Dynamics
  • "KMT2A partner genes in infant acute lymphoblastic leukemia have prognostic significance and correlate with age, white blood cell count, sex, and central nervous system involvement: a Children's Oncology Group P9407 trial study," 2023, Haematologica
  • "Expanding the genotypic and phenotypic spectrum in a diverse cohort of 104 individuals with Wiedemann-Steiner Syndrome," 2021, Molecular Genetics and Metabolism

Their frequent co-authors include Patrizia Porazzi, J. W. Davenport, Stephen P. Hunger, Sarah E. Sheppard, and Ian M. Campbell. These collaborative relationships emphasize interdisciplinary approaches across genetics, hematology, and clinical research.

Common venues for publication reflect the scientist's focus on hematology, genetics, and molecular medicine. These journals include Blood, American Journal of Medical Genetics Part A, Developmental Dynamics, Haematologica, and Molecular Genetics and Metabolism.

Best Publications

  • Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemia

    W.-J. Song;M. G. Sullivan;R. D. Legare;S. Hutchings

  • SECONDARY LEUKEMIAS INDUCED BY TOPOISOMERASE-TARGETED DRUGS

    Carolyn A. Felix

  • High incidence of secondary brain tumours after radiotherapy and antimetabolites

    Mary V. Relling;Mary V. Relling;Jeffrey E. Rubnitz;Jeffrey E. Rubnitz;Gaston K. Rivera;Gaston K. Rivera;James M. Boyett;James M. Boyett

  • Association of CYP3A4 genotype with treatment-related leukemia

    Carolyn A. Felix;Amy H. Walker;Beverly J. Lange;Terence M. Williams

  • The Molecular Basis of Leukemia

    D. Gary Gilliland;Craig T. Jordan;Carolyn A. Felix

  • DNA Topoisomerase II in Therapy-Related Acute Promyelocytic Leukemia

    Anita R. Mistry;Carolyn A. Felix;Ryan J. Whitmarsh;Annabel Mason

  • Leukemias related to treatment with DNA topoisomerase II inhibitors.

    Carolyn A. Felix

  • Frequency and Diversity of p53 Mutations in Childhood Rhabdomyosarcoma

    Carolyn A. Felix;Cynthia Chavez Kappel;Tetsuya Mitsudomi;Marion M. Nau

  • Maternal Diet and Infant Leukemia: The DNA Topoisomerase II Inhibitor Hypothesis: A Report from the Children's Oncology Group

    Logan G. Spector;Yang Xie;Leslie L. Robison;Nyla A. Heerema

  • Topoisomerase II and leukemia

    MaryJean Pendleton;R. Hunter Lindsey;Carolyn A. Felix;David Grimwade

  • t(11;22)(q23;q11.2) in acute myeloid leukemia of infant twins fuses MLL with hCDCrel, a cell division cycle gene in the genomic region of deletion in DiGeorge and velocardiofacial syndromes

    Maureen D. Megonigal;Eric F. Rappaport;Douglas H. Jones;Terence M. Williams

  • Topoisomerase II and the etiology of chromosomal translocations.

    Carolyn A. Felix;Christos P. Kolaris;Neil Osheroff

  • ALL-1 gene rearrangements in DNA topoisomerase II inhibitor-related leukemia in children

    Carolyn A. Felix;Matthew R. Hosler;Naomi J. Winick;Margaret Masterson

  • Chromosome Band 11q23 Translocation Breakpoints Are DNA Topoisomerase II Cleavage Sites

    Carolyn A. Felix;Beverly J. Lange;Matthew R. Hosler;Jolanta Fertala

  • 1,4-Benzoquinone is a topoisomerase II poison.

    R. Hunter Lindsey;Kenneth D. Bromberg;Carolyn A. Felix;Neil Osheroff

  • The t(11;20)(p15;q11) chromosomal translocation associated with therapy-related myelodysplastic syndrome results in an NUP98-TOP1 fusion.

    Harish G. Ahuja;Carolyn A. Felix;Carolyn A. Felix;Carolyn A. Felix;Peter D. Aplan;Peter D. Aplan;Peter D. Aplan

  • Gene expression profiles predictive of outcome and age in infant acute lymphoblastic leukemia: A Children's Oncology Group study.

    Huining Kang;Carla S. Wilson;Richard C. Harvey;I. Ming Chen;I. Ming Chen

  • Potential topoisomerase II DNA-binding sites at the breakpoints of a t(9;11) chromosome translocation in acute myeloid leukemia

    M. Negrini;C. A. Felix;C. Martin;B. J. Lange

  • Therapy-related acute myeloid leukemia-like MLL rearrangements are induced by etoposide in primary human CD34+ cells and remain stable after clonal expansion.

    Jolanta Libura;Diana J. Slater;Diana J. Slater;Diana J. Slater;Carolyn A. Felix;Carolyn A. Felix;Carolyn A. Felix;Christine Richardson;Christine Richardson;Christine Richardson

  • Detection of leukemia-associated MLL-GAS7 translocation early during chemotherapy with DNA topoisomerase II inhibitors

    Maureen D. Megonigal;Nai-Kong V. Cheung;Eric F. Rappaport;Peter C. Nowell

Frequent Co-Authors

Beverly J. Lange
Beverly J. Lange Children's Hospital of Philadelphia
Eric F. Rappaport
Eric F. Rappaport Children's Hospital of Philadelphia
Neil Osheroff
Neil Osheroff Vanderbilt University
Peter C. Nowell
Peter C. Nowell University of Pennsylvania
Stephen P. Hunger
Stephen P. Hunger University of Pennsylvania
Cheryl L. Willman
Cheryl L. Willman University of New Mexico
Naomi J. Winick
Naomi J. Winick The University of Texas Southwestern Medical Center
Nyla A. Heerema
Nyla A. Heerema The Ohio State University
Andrew J. Carroll
Andrew J. Carroll University of Alabama at Birmingham
Ian A. Blair
Ian A. Blair University of Pennsylvania

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring molecular biology in the USA can open doors to many other fields. For students interested in interdisciplinary study, combining biology with other sciences or mathematics can provide a competitive edge. Pursuing an online math degree is a great way to deepen your analytical skills and expand career options in research or biotechnology.

If you are drawn to supporting individuals and communities, a human services degree online offers a flexible pathway to roles that combine science with social impact. Those with a background in molecular biology may also consider making a career shift; for example, moving from education to healthcare as detailed in our guide on making a career change from teacher to speech and language therapist.

Additionally, molecular biology links closely with design and problem-solving. Attending an online architecture school is another innovative route, as many modern architecture programs value scientific thinking and sustainable solutions.

Best Scientists Citing Carolyn A. Felix

Trending Scientists

Recently Published Articles